Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Uterine Cervical Neoplasms 9Squamous Cell Carcinoma of Head and Neck 7Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Urinary Bladder Neoplasms 4Mesothelioma, Malignant 4Urethral Neoplasms 3Small Cell Lung Carcinoma 3Oropharyngeal Neoplasms 3Neuroblastoma 3Medulloblastoma 3Ganglioneuroblastoma 3Cholangiocarcinoma 3Vulvar Neoplasms 2Vaginal Neoplasms 2Ureteral Neoplasms 2Tongue Neoplasms 2Prostatic Neoplasms 2Lymphoid Interstitial Pneumonia 2Laryngeal Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Transitional Cell 2Brenner Tumor 2Vomiting 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solitary Fibrous Tumor, Pleural 1Sertoli-Leydig Cell Tumor 1

Interventions

Cisplatin 9Cetuximab 6Radiotherapy, Intensity-Modulated 5Docetaxel 4Radiotherapy 3Fluorouracil 3Carboplatin 3pembrolizumab 2durvalumab 2Radiation 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2sodium thiosulfate 1gossypol acetic acid 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Pilocarpine 1Oral Hygiene 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Laryngeal Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT04030455 2026-03-09

Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
28 enrolled 13 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms

NCT04541355 2024-06-28

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

University of California, San Francisco

Phase 2 Completed
16 enrolled 12 charts
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡